a fund of the Natural Science Foundation of Shandong(No.Y2004C34)
Background Hepatocellular carcinoma (HCC) ranked the second among the causes of cancer mortality in China since the 1990s. Up to now, medication still plays an important role in the treatment of HCC. The therapies b...
This study was supported by a grant from the National 863 Program of China (No. 2002AA216011).
Background Liver targeting drug delivery systems can improve the curative effects and relieve the cytotoxicity of the chemotherapy drugs in the treatment of liver diseases. Nanoparticles carrying therapeutic drugs are...